+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ethylenediamine Tetraacetic Acid (EDTA) Tubes - Global Strategic Business Report

  • PDF Icon

    Report

  • 371 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6110408
The global market for Ethylenediamine Tetraacetic Acid (EDTA) Tubes was valued at US$2.1 Billion in 2025 and is projected to reach US$3.2 Billion by 2032, growing at a CAGR of 6.3% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market - Key Trends & Drivers Summarized

Why Are EDTA Tubes Considered Essential in Modern Diagnostic and Clinical Laboratories?

Ethylenediamine tetraacetic acid (EDTA) tubes are commonly used blood collection containers pre-coated with EDTA as an anticoagulant. These tubes are critical for hematology tests because EDTA effectively binds calcium ions, preventing clot formation and preserving blood cell morphology. They are widely used for complete blood counts (CBC), blood typing, molecular diagnostics, and various DNA or RNA-based tests.

The precision and reliability of blood-based diagnostics heavily depend on the integrity of the collected specimen. EDTA tubes maintain cellular structure for hours after collection, enabling accurate analysis of white and red blood cells, platelets, and nucleic acids. Their widespread use across hospitals, diagnostic labs, blood banks, and research facilities makes them indispensable in routine and specialized laboratory workflows.

What Are the Emerging Material and Design Improvements in EDTA Tubes?

Manufacturers are refining EDTA tubes through improvements in material quality, closure systems, and anticoagulant formulations. Most tubes are made of glass or plastic (polyethylene terephthalate or polypropylene), with plastic variants gaining preference due to their reduced breakage risk and lighter weight. Innovations include screw caps, safety closures, and vacuum-sealed designs to ensure contamination-free collection and processing.

Uniform coating of spray-dried or liquid EDTA ensures consistent anticoagulant action. Color-coded caps, primarily lavender or purple, are standardized across regions to facilitate quick identification in labs. Some manufacturers are integrating barcode labels, volume indicators, and RFID chips for improved tracking and sample handling. Additions such as gel separators or clot activators are also being explored for specific use cases, enhancing sample quality across diverse diagnostics.

Where Is Demand Expanding, and Who Are the Core End-Users?

EDTA tube demand is expanding globally due to the increasing number of diagnostic procedures and the rising burden of chronic and infectious diseases. Core users include clinical laboratories, hospitals, pathology labs, blood banks, biobanks, and academic research centers. Rapid growth in preventive screening, personalized medicine, and infectious disease testing has also increased the frequency of blood draws, thereby fueling tube usage.

High-volume markets include North America and Europe, supported by advanced healthcare infrastructure and routine use of automated hematology analyzers. Asia Pacific is witnessing strong growth due to expanding diagnostic networks, urban healthcare access, and rising investments in laboratory automation. In emerging markets, government programs for public health diagnostics are contributing to increased procurement of standardized blood collection systems.

What Is Driving Growth in the EDTA Tubes Market?

Growth in the EDTA tubes market is driven by several factors including rising global diagnostic volumes, increased focus on blood-based disease screening, and the expanding reach of clinical laboratories. Technological improvements in blood collection systems, enhanced compatibility with automated analyzers, and better anticoagulant stability are reinforcing product relevance.

End-use expansion in molecular diagnostics, cancer genomics, and population health studies is increasing reliance on EDTA-preserved blood samples. Growth in home diagnostics and point-of-care testing is also supporting innovation in portable and safe blood collection devices. As healthcare delivery systems become more diagnostic-centered and lab automation increases, EDTA tubes will continue to be a foundational element of clinical sample management.

Report Scope

The report analyzes the Ethylenediamine Tetraacetic Acid (EDTA) Tubes market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Type (K2 EDTA Tube, K3 EDTA Tube); Application (Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application, Other Applications); End-Use (Hospitals End-Use, Diagnostics Centers End-Use, R&D Centers End-Use, Other End-Uses)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the K2 EDTA Tube segment, which is expected to reach US$1.9 Billion by 2032 with a CAGR of a 5.1%. The K3 EDTA Tube segment is also set to grow at 8.0% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $575.7 Million in 2025, and China, forecasted to grow at an impressive 9.4% CAGR to reach $664.7 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as AdvaCare Pharma, APT Medical, BD - Becton, Dickinson and Company, CDRICH, F.L. Medical srl and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Ethylenediamine Tetraacetic Acid (EDTA) Tubes market report include:

  • AdvaCare Pharma
  • APT Medical
  • BD - Becton, Dickinson and Company
  • CDRICH
  • F.L. Medical srl
  • Gong Dong (Zhejiang Gongdong)
  • Greiner Bio-One AG (GBO)
  • Guangzhou Jiuan Medical Equipment Co. Ltd
  • Haemonetics Corp.
  • Hongyu Medical
  • Improve Medical
  • Medtronic PLC
  • Narang Medical Pvt Ltd
  • Sanli Medical
  • Sarstedt AG & Co.
  • Sekisui Diagnostics
  • Shanghai Biyun Medical Technology Co. Ltd
  • Terumo Corporation
  • TUD (Tianjin Union Development)
  • Vitrex Medical A/S

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Global Focus on Preventive Healthcare and Diagnostic Testing Drives Demand for EDTA Blood Collection Tubes
  • Expansion of Clinical Laboratory Infrastructure in Emerging Markets Strengthens Market Penetration of EDTA Tubes
  • Increasing Incidence of Infectious and Chronic Diseases Spurs Routine Use of EDTA Tubes in Hematological Testing
  • Standardization of Blood Sample Collection Protocols in Hospitals Enhances Demand for Pre-Prepared EDTA Tubes
  • OEM Innovation in Non-Glass, Shatterproof Tube Materials Supports Safety and Convenience in Sample Handling
  • Regulatory Compliance for Blood Sample Preservation Drives Preference for EDTA Tubes in Plasma and CBC Testing
  • Growth in Global Blood Donation and Transfusion Services Sustains Large-Scale Demand for EDTA Tubes in Blood Banks
  • Automation in Diagnostic Laboratories Throws the Spotlight on EDTA Tubes with Robotic Compatibility and Barcode Labeling
  • Increased Adoption of Vacuum Blood Collection Systems Enhances Efficiency and Reduces Contamination R
  • Integration of EDTA Tubes in Point-of-Care Testing and Mobile Health Clinics Expands Access in Rural and Remote Settings
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for K2 EDTA Tube by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for K2 EDTA Tube by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for K2 EDTA Tube by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for K3 EDTA Tube by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for K3 EDTA Tube by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for K3 EDTA Tube by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for R&D Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for R&D Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for R&D Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Diagnostics Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Diagnostics Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Diagnostics Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Complete Blood Count Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Complete Blood Count Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Complete Blood Count Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Blood Smear Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Blood Smear Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Blood Smear Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Coagulation Tests Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Coagulation Tests Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Coagulation Tests Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Bone Marrow Biopsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Bone Marrow Biopsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Bone Marrow Biopsy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 37: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AdvaCare Pharma
  • APT Medical
  • BD – Becton, Dickinson and Company
  • CDRICH
  • F.L. Medical srl
  • Gong Dong (Zhejiang Gongdong)
  • Greiner Bio-One AG (GBO)
  • Guangzhou Jiuan Medical Equipment Co. Ltd
  • Haemonetics Corp.
  • Hongyu Medical
  • Improve Medical
  • Medtronic PLC
  • Narang Medical Pvt Ltd
  • Sanli Medical
  • Sarstedt AG & Co.
  • Sekisui Diagnostics
  • Shanghai Biyun Medical Technology Co. Ltd
  • Terumo Corporation
  • TUD (Tianjin Union Development)
  • Vitrex Medical A/S

Table Information